AOL Money & Finance

Option update: GlaxoSmithKline volatility flat following earnings warning

More

GlaxoSmithKline (NYSE: GSK) is recently down $3.75 to $42.13.

GSK reported a declining Q4 pre-tax profit and warned 2008 earnings will be negatively affected by decreasing sales of diabetes drug Avandia, competition from generics and a weak dollar.

GSK overall option implied volatility of 26 is near its 26-week average according to Track Data, suggesting non-directional risk.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Symbol Lookup
IndexesChangePrice
DJIA+203.5210,226.94
NASDAQ+41.622,154.06
S&P 500+23.781,093.08

Last updated: November 10, 2009: 08:17 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines